Cancer Risk May Be Set Before Birth, Groundbreaking Study Finds
A revolutionary study by scientists at the Van Andel Institute (VAI) suggests that an individual’s lifelong susceptibility to cancer may be largely determined even before they are born. Published in the prestigious journal Nature Cancer, the research has upended conventional understanding of cancer development, highlighting the critical role of epigenetics – the study of how our genes are expressed – in shaping our future health.
The study identified two distinct epigenetic states that emerge during fetal development and are directly linked to cancer risk. These states are not caused by alterations to the underlying DNA sequence itself, but rather by molecular modifications that act like switches, influencing how our genes are turned on or off. One state is associated with a lower lifetime cancer risk, while the other is linked to a significantly higher risk.
"Most cancers develop later in life and have traditionally been viewed as diseases of genetic mutations," explains Dr. J. Andrew Pospisilik, chair of the Department of Epigenetics at VAI and a co-corresponding author of the study. "Our findings demonstrate that the origins of cancer risk can be traced back much earlier, to the critical developmental period in the womb. This shifts our understanding in a profound way."
The link between these epigenetic states and specific cancer types is striking. If cancer does occur in the lower-risk state, it’s more likely to be a liquid tumor, such as leukemia or lymphoma. In contrast, the higher-risk state is strongly associated with solid tumors, including lung and prostate cancer.
"While bad luck often plays a role in cancer development, this doesn’t fully explain why some people are more susceptible than others," says Dr. Ilaria Panzeri, a research scientist in the Pospisilik Lab and the study’s first and co-corresponding author. "Our findings suggest that epigenetic errors during development may disrupt the delicate mechanisms that control cell growth and repair, paving the way for cancer to emerge later in life. Importantly, because epigenetics is potentially modifiable, these discoveries offer exciting new avenues for prevention and treatment."
The potential implications of this groundbreaking research are far-reaching. The discovery of these distinct epigenetic states in various tissues suggests that developmental epigenetic risk may be a common factor across a wide spectrum of cancers. The research team at VAI is now delving deeper into the effects of these states within specific cancer types, paving the way for more personalized and targeted approaches to cancer prevention and treatment. This research opens a new chapter in our understanding of cancer, offering hope for more effective strategies to combat this devastating disease.